Kyiv, Vyshgorodska str., 67 (entrance off Kobzarska str.), 4th floor, room 105        



Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169.



According to the revised European Working Group on Sarcopenia in Older People (EWGSOP) consensus of 2019, sarcopenia is a progressive and generalised skeletal muscle disorder that is associated with increased likelihood of adverse outcomes including falls, fractures, physical disability and mortality.


In September 2016, the diagnosis of sarcopenia was officially included in the supplemented 10th international classification of diseases under the code M 62.84


Diagnostic criteria (EWGSOP, 2019):

  1. Low muscle strength
  2. Low muscle quantity or quality
  3. Low physical performance


Sarcopenia stages (EWGSOP, 2019)


Skeletal muscle strength

Skeletal muscle mass/quality


Skeletal muscle performance

Probable sarcopenia






Severe sarcopenia



Sarcopenia “cut-off” points (EWGSOP, 2019)

Diagnostic test



Skeletal muscle strength “cut-off” points

Grip strength, kg

(hand dynamometrics)

< 27

< 16

Chair stand

> 15 sec / 5 times

not available

Skeletal muscle mass “cut-off” points

Appendicular Lean Mass (ALM), kg

< 20

< 15

Appendicular Lean Mass index , kg/m2

< 7.0

< 6.0

Skeletal muscle performance “cut-off” points

Gait speed, m/sec

≤ 8

not available

SPPB test

≤ 8

“3-m walk” test, sec


“400-m walk” test, sec

Failure or performance ≥ 6 minutes



2019 EWGSOP’s updated diagnostic («Find-Asess-Confirm-Severity» (F-A-C-S)) algorithm targeted at sarcopenia





SARC-F: sarcopenia diagnostic questionnaire


Interpretation of findings: total value of over 4 points indicates a high probability of sarcopenia and its adverse consequences in an examined patient.




N.I. Dzerovych

2019 European recommendations on sarcopenia diagnosis